Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Compugen Announces Exclusive License Agreement With MedImmune
Tuesday, April 03, 2018Compugen Ltd a leader in predictive discovery and development of firstinclass therapeutics for cancer immunotherapy today announced it entered into an exclusive license agreement with MedImmune the global biologics research and development arm of Ast...
PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme
Monday, April 02, 2018PharmAbcine Inc a clinicalstage biotech company developing novel antibody therapeutics for multiple cancer indications announced today that US Food and Drug Administration FDA has granted orphan drug designation to its leading clinical compound TTAC...
Martin Pharmaceuticals Receives FDA Orphan Drug Designation for LIVANTRA™
Saturday, March 31, 2018Martin Pharmaceuticals a clinical stage pharmaceutical company focused on repurposing alreadyapproved drugs to offer lifechanging advances to patients afflicted with rare orphan diseases or challenging medical conditions has been granted Orphan Drug...
Ligand Enters into Agreement with venBio to Make Worldwide OmniAb® Platform License Accessible to Portfolio Companies
Saturday, March 31, 2018Ligand Pharmaceuticals Incorporated announces it has entered into an agreement with venBio Partners a venture capital group focused on building and funding portfolio companies with potential first and bestinclass therapeutic product applications whic...
Actinium Pharmaceuticals Announces Collaborative Research Partnership with Astellas Leveraging Actinium’s AWE Platform Technology
Thursday, March 29, 2018Actinium Pharmaceuticals Inc announced that it has entered into a research and option agreement with Astellas Pharma Inc to develop Actinium RadioConjugates ARCs using its Actinium Warhead Enabling AWE Platform Technology Under this collaboration Act...
Abide and Celgene Enter Worldwide License Agreement for ABX-1772
Thursday, March 29, 2018Abide Therapeutics a clinicalstage biopharmaceutical company focused on developing novel therapeutics targeting the serine hydrolase family of enzymes announced today it has granted Celgene an exclusive worldwide license for ABX a preclinical drug ca...
Oncodesign Concludes a Long Term Service-Based Partnership with ERYTECH in Oncology
Wednesday, March 28, 2018Oncodesign a biopharma company specialized in precision medicine with the mission of discovering new therapeutic molecules to fight cancer and other serious illnesses with no known effective treatment is announcing that it has concluded a servicebase...
Eagle Pharmaceuticals Announces New Patent for Eagle Biologics
Wednesday, March 28, 2018Eagle Pharmaceuticals Inc announced that the Companys Eagle Biologics division has been issued a new patent by the United States Patent and Trademark Office USPTO Patent number will expire in March and is the third one issued in the Eagle Biologics...
Syngene International Signs R&D Agreement with GSK
Tuesday, March 27, 2018Syngene International a leading global contract research services company today announced an RD agreement with GSK a scienceled global healthcare company The multiyear agreement will focus on accelerating the discovery of new drug candidates using Sy...
Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation for Enfortumab Vedotin
Tuesday, March 27, 2018Seattle Genetics Inc and Astellas Pharma Inc today announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to enfortumab vedotin an antibodydrug conjugate ADC for patients with locally advanced or metastati...
